Open Offer22 Jul 2026, 01:42 pm
Parmax Pharma: Open Offer Launched by Acquirers for 26% Stake
AI Summary
Fedex Securities Pvt Ltd, acting as the Manager to the Offer, has submitted a Letter of Offer to BSE for the public shareholders of Parmax Pharma Ltd. This document details an open offer by Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with several Persons Acting in Concert (PACs), to acquire up to 23,46,250 equity shares. These shares represent 26.00% of the expanded voting capital of Parmax Pharma. The offer price is set at ₹42.80 per equity share, and the transaction is being conducted in accordance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Key Highlights
- Open offer by Acquirers and PACs for Parmax Pharma shares.
- Acquisition of up to 26% of expanded voting capital.
- Offer price set at ₹42.80 per equity share.
- Transaction complies with SEBI (SAST) Regulations, 2011.
Price Impact
More from PARMAX